← Open Payments lookup

DANIEL CHANG: Open Payments

NPI 1922727353 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,290 in 33 payments from 10 companies in 2025. Trend: 2023 $1,904 · 2024 $1,757 · 2025 $1,290

Food & beverage: $1,290
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$230
Janssen Pharmaceuticals, Inc8$180
Teva Pharmaceuticals USA, Inc.3$148
Alkermes, Inc.2$140
Vanda Pharmaceuticals Inc.2$139
E.R. Squibb & Sons, L.L.C.5$133
Axsome Therapeutics, Inc.1$124
ABBVIE INC.4$93
Alpha Cognition USA, Inc.1$78
Lundbeck LLC1$26

Products named: CAPLYTA, SPRAVATO, UZEDY, FANAPT, COBENFY, Auvelity, LYBALVI, VRAYLAR.

Industry payments across CA — which companies pay providers there.